Mark L. Berch

Array ( [id] => 3690411 [patent_doc_number] => 05696265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Vinyl ethers of nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/488340 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28536 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696265.pdf [firstpage_image] =>[orig_patent_app_number] => 488340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103755 [patent_doc_number] => 06100271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Therapeutic compounds containing xanthinyl' [patent_app_type] => 1 [patent_app_number] => 8/483871 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17943 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100271.pdf [firstpage_image] =>[orig_patent_app_number] => 483871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4092386 [patent_doc_number] => 06133444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions' [patent_app_type] => 1 [patent_app_number] => 8/487666 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23332 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133444.pdf [firstpage_image] =>[orig_patent_app_number] => 487666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3631170 [patent_doc_number] => 05686611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/488339 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28529 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686611.pdf [firstpage_image] =>[orig_patent_app_number] => 488339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032074 [patent_doc_number] => 05994361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Substituted purinyl derivatives with immunomodulating activity' [patent_app_type] => 1 [patent_app_number] => 8/474073 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22682 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994361.pdf [firstpage_image] =>[orig_patent_app_number] => 474073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306744 [patent_doc_number] => 06187916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Process for the preparation of taxane derivatives and .beta.-lactam intermediates therefor' [patent_app_type] => 1 [patent_app_number] => 8/481205 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15080 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187916.pdf [firstpage_image] =>[orig_patent_app_number] => 481205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3898289 [patent_doc_number] => 05750685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Process for preparing potassium clavulanate in rossette form' [patent_app_type] => 1 [patent_app_number] => 8/481213 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 5250 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750685.pdf [firstpage_image] =>[orig_patent_app_number] => 481213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807840 [patent_doc_number] => 05854228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/473826 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17279 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854228.pdf [firstpage_image] =>[orig_patent_app_number] => 473826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871844 [patent_doc_number] => 05837871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/486991 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28636 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837871.pdf [firstpage_image] =>[orig_patent_app_number] => 486991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815618 [patent_doc_number] => 05710272 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => '7-methoxymethly-3-methyl-1-(5-oxohexyl)xanthine' [patent_app_type] => 1 [patent_app_number] => 8/480801 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4439 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710272.pdf [firstpage_image] =>[orig_patent_app_number] => 480801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706698 [patent_doc_number] => 05654309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Pyridopyrimidine derivatives, their production and use' [patent_app_type] => 1 [patent_app_number] => 8/480862 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23092 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654309.pdf [firstpage_image] =>[orig_patent_app_number] => 480862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614046 [patent_doc_number] => 05510343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Bicyclic and tricyclic .beta.-lactams' [patent_app_type] => 1 [patent_app_number] => 8/474207 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25209 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510343.pdf [firstpage_image] =>[orig_patent_app_number] => 474207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661644 [patent_doc_number] => 05656617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Derivatives of purine, process for their preparation and a pharmaceutical preparation' [patent_app_type] => 1 [patent_app_number] => 8/476348 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8693 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656617.pdf [firstpage_image] =>[orig_patent_app_number] => 476348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733652 [patent_doc_number] => 05693798 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Phosphonate nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/488337 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28562 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693798.pdf [firstpage_image] =>[orig_patent_app_number] => 488337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940261 [patent_doc_number] => 05981535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases' [patent_app_type] => 1 [patent_app_number] => 8/474093 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9290 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981535.pdf [firstpage_image] =>[orig_patent_app_number] => 474093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695847 [patent_doc_number] => 05661148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Pyrrolo[2,3-d]pyrimidine derivatives, process for producing the same and pharmaceutical preparation comprising the same as active ingredient' [patent_app_type] => 1 [patent_app_number] => 8/478686 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14952 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661148.pdf [firstpage_image] =>[orig_patent_app_number] => 478686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3792982 [patent_doc_number] => 05726174 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/488338 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28527 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726174.pdf [firstpage_image] =>[orig_patent_app_number] => 488338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775376 [patent_doc_number] => 05756735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Xanthine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/483159 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11049 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756735.pdf [firstpage_image] =>[orig_patent_app_number] => 483159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775575 [patent_doc_number] => 05817661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Trans cyclopentanyl purine analogs useful as immunosuppressants' [patent_app_type] => 1 [patent_app_number] => 8/485745 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9922 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817661.pdf [firstpage_image] =>[orig_patent_app_number] => 485745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772310 [patent_doc_number] => 05734051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => '8-substituted xanthine derivatives and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/477157 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9279 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734051.pdf [firstpage_image] =>[orig_patent_app_number] => 477157 [rel_patent_id] =>[rel_patent_doc_number] =>)